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a b s t r a c t
Cell surface structures initiating attachment of Kaposi0s sarcoma-associated herpesvirus (KSHV) were
characterized using puriﬁed hapten-labeled virions visualized by confocal microscopy with a sensitive
ﬂuorescent enhancement using tyramide signal ampliﬁcation (TSA). KSHV attachment sites were present
in speciﬁc cellular domains, including actin-based ﬁlopodia, lamellipodia, rufﬂed membranes, microvilli
and intercellular junctions. Isolated microdomains were identiﬁed on the dorsal surface, which were
heterogeneous in size with a variable distribution that depended on cellular conﬂuence and cell cycle
stage. KSHV binding domains ranged from scarce on interphase cells to dense and continuous on mitotic
cells, and quantitation of bound virus revealed a signiﬁcant increase on mitotic compared to interphase
cells. KSHV also bound to a supranuclear domain that was distinct from microdomains in conﬂuent and
interphase cells. These results suggest that rearrangement of the cellular membrane during mitosis
induces changes in cell surface receptors implicated in the initial attachment stage of KSHV entry.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The Kaposi0s sarcoma-associated herpesvirus/human herpes-
virus 8 (KSHV) is the causative agent of Kaposi0s sarcoma, pleural
effusion lymphoma and multicentric Castleman0s disease (Ganem,
2006). In vitro, KSHV infects a broad spectrum of cells, including
lymphocytic, endothelial, epithelial and mesenchymal cells (Bechtel
et al., 2003; Lagunoff et al., 2002). Initiation of the infectious process
of KSHV and other herpesviruses is believed to involve the attach-
ment to heparan sulfate (HS), which is ubiquitously expressed on
proteoglycans at the cell surface (Akula et al., 2001b; Birkmann et al.,
2001; Liu and Thorp, 2002). Several KSHV virion proteins bind HS,
including glycoprotein B (Akula et al., 2001a), K8.1 (Birkmann et al.,
2001; Wang et al., 2001), glycoprotein H (Hahn et al., 2009) and
complement control protein (KCP) (Mark et al., 2006). Enzymatic
removal of cell surface HS results in reduced susceptibility of target
cells to KSHV infection (Akula et al., 2001b), and cells that express
low levels of HS are resistant to KSHV infection (Jarousse et al.,
2008). Virion interactions with HS proteoglycans are believed to
concentrate virus on cell surface domains to promote virus entry
through additional cell surface entry receptors. Several cell surface
proteins have been implicated as KSHV entry receptors, including
DC-SIGN (Rappocciolo et al., 2008; Rappocciolo et al., 2006), the
cystine transporter (xCT) light chain (Kaleeba and Berger, 2006) and
CD98 heavy chain heterodimer (Veettil et al., 2008), the ephrin
receptor tyrosine kinase A2 (EphA2)(Hahn et al., 2012), syndecan
(Hahn et al., 2009, 2012), and the integrins α3β1, αvβ3 and αvβ5
(Akula et al., 2002; Garrigues et al., 2008; Veettil et al., 2008).
Previous studies have focused on KSHV/receptor interactions
occurring after initial virus contact with the plasma membrane.
Time-dependent translocation of KSHV into lipid rafts along with
αvβ3 and α3β1 integrins and xCT receptors was observed in
endothelial cells (Veettil et al., 2008). However, there is limited
morphological data correlating the position of cell surface bound
KSHV with the distribution of HS or other entry receptors at initial
attachment sites before virus entry.
Advances in ﬂuorescence technologies coupled with confocal
microscopy have provided novel approaches to visualize viruses
and their interaction with cell surfaces. Virion particles have been
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labeled using a variety of different approaches, including incor-
poration of exogenous ﬂuorescent proteins, such as green ﬂuor-
escent protein (GFP), as fusions with virion structural proteins, or
incorporation of ﬂuorescent dyes in the lipid virion envelope
membrane (Balogh et al., 2011). Indirect ﬂuorescent techniques
utilize the incorporation of small peptide tags, such as tetracys-
teine, fused in-frame with virion proteins (Whitt and Mire, 2011)
or chemical labeling of virion proteins using small haptens with
the addition of ﬂuorophores that covalently or non-covalently
interact with the modiﬁed proteins. While all of these approaches
have been utilized to visualize virus interactions with cell surfaces,
each is associated with potential problems of sensitivity and
speciﬁcity of detection and efﬁciency and ease of labeling.
To identify KSHV plasma membrane binding domains, we
developed and optimized a highly sensitive technique to visualize
hapten-labeled KSHV virions bound to target cells using confocal
ﬂuorescence microscopy with tyramide signal ampliﬁcation (TSA)
and 3D‐surface rendering. The TSA enhancement technique was
500 fold more sensitive than conventional immunoﬂuorescence,
and allowed us to identify speciﬁc cell surface microdomains that
bind KSHV during the initial attachment phase of infection. The
distribution of KSHV binding microdomains was dependent on cell
density in conﬂuent and sub-conﬂuent cultures, and increased
binding was detected on mitotic cells. The characterization of the
KSHV attachment domains along with improved virus detection
will allow us to determine if HS or other proposed entry receptors
are present in KSHV microdomains and determine whether the
increased binding of mitotic cells correlates with a particular
receptor constitution within the KSHV microdomains.
Results
Puriﬁcation of hapten-labeled infectious KSHV virions
In order to characterize cell membrane domains that mediate
the initial attachment and entry of KSHV, we developed a highly
sensitive tyramide signal ampliﬁcation (TSA) method to visualize
cell bound hapten-labeled virus. KSHV virions from culture super-
natants of TPA treated KSHV infected BCBL-1 cells were labeled
with the hapten dinitrophenol (DNP) and subsequently puriﬁed on
an Opti-Prep step gradient, as described previously (Garrigues
et al., 2008). PCR analysis of gradient fractions identiﬁed a major
peak of labeled KSHV in fractions 10 and 11 (Fig. 1A). Selected
fractions (5, 7, 9, 11, 13, and 15) were screened for the presence of
infectious virus using Vero cells as target, and the percent of
infected cells expressing the KSHV ORF73 latency-associated
nuclear antigen (LANA), a marker of KSHV latent infection, was
determined, as described in Materials and methods. The major
peak of viral DNA, fraction 11 was highly infectious in comparison
to the other tested fractions (Fig. 1A).
To determine if hapten incorporation altered KSHV infectivity,
gradient puriﬁed KSHV virions were labeled with increasing
concentrations of DNP or biotin. The labeled virus was puriﬁed
from unincorporated hapten and used to infect Vero cells. The
percent of infected cells was determined by staining for LANA
expression. Hapten concentrations up to 50 mg/ml of DNP or biotin
did not signiﬁcantly affect KSHV infectivity when compared to
control unlabeled virus (Fig. 1B). A hapten concentration of 10 mg/
ml was chosen for labeling KSHV virions for the remainder of
the study.
Our initial attempts to visualize the distribution of cell bound
DNP-KSHV using anti-DNP in combination with FITC labeled
secondary antibodies were unsuccessful due to the low sensiti-
vity of this unampliﬁed ﬂuorescent technique. For this reason we
investigated a signal ampliﬁcation technique using ﬂuorescent
tyramide.
Tyramide signal ampliﬁcation enhances the sensitivity of KSHV
detection
Tyramide signal ampliﬁcation (TSA) is an enzyme mediated
detection method reported to be a 100-fold more sensitive than
conventional ﬂuorescent methods (Bobrow et al., 1989; Speel et al.,
1999). TSA enhancement is achieved with an antibody coupled to
horse radish peroxidase (HRP), which catalyzes the activation of
ﬂuorescent tyramide that becomes covalently linked to tyrosine
residues in proteins at the site of the localized HRP-antibody. Our
initial assessment was done using an indirect immunoassay with
biotinylated IgG coupled to magnetic beads. The beads were
incubated with mouse anti-biotin IgG and dilutions of goat anti-
mouse IgG conjugated with either HRP or FITC. The FITC ﬂuores-
cence was measured directly while the HRP activity was detected
using signal enhancement with TSA488. A strong ﬂuorescent TSA
signal (113.8715 MFI) was observed at the bead surface using a
1:20,000 dilution of anti-mouse-HRP (Fig. 2A). The same second-
ary antibody labeled with FITC gave a weak ﬂuorescent signal even
at a 200-fold higher concentration of antibody (43.4716 MFI)
(Fig. 2B). Factoring in the difference in ﬂuorescent signal and the
antibody dilutions, the TSA method was approximately 500 fold
more sensitive than the FITC method, conﬁrming previous esti-
mates (Bobrow et al., 1989; Speel et al., 1999).
To determine whether the TSA enhanced ﬂuorescence was
sufﬁcient to detect individual KSHV virion particles by confocal
microscopy, gradient puriﬁed biotin-labeled KSHV (bio-KSHV)
virions were attached to poly-L-lysine coated slides. Bound virus
particles were incubated with mouse anti-biotin IgG or mouse
anti- KSHV virion envelope glycoprotein K8.1 followed by HRP
conjugated anti-mouse IgG and TSA488. Individual virion particles
were readily detected with antibodies to both biotin (Fig. 2C) and
K8.1 (Fig. 2D). Analysis of the TSA-enhanced virion particle
ﬂuorescence using the Zeiss software revealed that the majority
of the particles were uniform in size and not aggregated. Subse-
quently, DNP-KSHV virions were sequentially stained with the
mouse anti-K8.1 and TSA488 (green) enhancement followed by rat
anti-DNP and TSA647 (red) enhancement, as described in Materi-
als and methods. Confocal microscopy revealed that the K8.1
glycoprotein staining co-localized with individual virion particles
labeled with DNP (Fig. 2E and F), with a overlap coefﬁcient of 0.9.
The presence of K8.1 reactivity showed that the puriﬁed DNP-
KSHV virions had intact envelopes, which correlated with the
highly infectious nature of the hapten-labeled virus. Thus, TSA
enhanced ﬂuorescence was sufﬁcient to detect virus particles by
confocal analysis.
Localization of TSA enhanced ﬂuorescence is highly speciﬁc and
accurate
Since the correct localization of the TSA ﬂuorescent product is
dependent on tyramide deposition at the binding site of the HRP-
labeled secondary antibody, we assessed the accuracy of TSA
deposition by examining the speciﬁc localization of TSA ﬂuores-
cence using monoclonal antibodies reacting with either cell sur-
face β3 integrin or two KSHV proteins, the ORF73 LANA and the
ORF59 DNA polymerase processivity factor. Previous studies have
shown that KSHV LANA localizes to discrete focal points in
irregularly shaped bodies that associate with the border of
heterochromatin in the nucleus of infected cells (Szekely et al.,
1999), whereas ORF59 localizes diffusely across the nucleus (Chan
et al., 1998). The antibody to β3 integrin was used to delineate the
cell surface. The monoclonal antibodies were visualized using
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tyramides with different ﬂuors and sequential TSA ampliﬁcation
reactions separated by intermediate peroxidase quenching steps to
block any residual peroxidase activity and allow simultaneous
detection of the different ﬂuorescent signals. Short 10 min TSA
ampliﬁcation reactions were used since inaccurate TSA localization
was observed using extended ampliﬁcations times of 30 min or
longer (van Gijlswijk et al., 1996).
Vero cells were infected with KSHV for 24 h and then incubated
with mouse anti-β3 integrin to label cell surface β3 integrin. The
cells were ﬁxed and the β3 integrin antibody was localized using
anti-mouse IgG-HRP and TSA488 (green). Residual peroxidase
activity was blocked by hydrogen peroxide and the cells were
permeabilized and incubated with either rat anti-LANA or mouse
anti-ORF59. Bound antibody was detected with species speciﬁc
HRP conjugated secondary antibodies and TSA594 (red) enhance-
ment. The cell nuclei were counterstained with TO-PRO 3 (blue),
an ultrasensitive dye that detects double-stranded nucleic acid.
Confocal ﬂuorescence microscopy revealed strong TSA
enhanced labeling of the cell borders with the anti-β3 integrin
antibody (Fig. 3A, green). The cell cytoplasm was unstained
(black), and the nuclei stained with TO-PRO 3 (blue). TSA
enhanced LANA ﬂuorescence was restricted to speciﬁc focal points
in the nucleus of the infected cells (Fig. 3A, red). The accuracy of
the TSA localization was further shown at higher magniﬁcation
where the TSA product was conﬁned solely to the nucleus in
discrete spots, even for spots directly adjacent to the nuclear
membrane (Fig. 3B). The TSA localization matched the localization
obtained previously with conventional FITC labeling with no
obvious diffusion of tyramide within or outside of the nucleus.
In Fig. 3C, the ORF 59 ﬂuorescence (red) was distributed through-
out the nucleus with a uniform pattern. Using the “proﬁle”
function of the Zeiss LSM Pascal software, the histogram showed
that none of the ORF 59 TSA product had diffused into the cell
cytoplasm, as all ORF59 pixels co-localized with TO-PRO 3 nuclear
dye (Fig. 3D). This was particularly evident at the nuclear mem-
brane edge where the histogram for both emissions overlapped
(arrowhead). Additionally, the histogram revealed a simultaneous
decrease in ORF 59 TSA (red) and nuclear DNA-associated TO-PRO
(blue) ﬂuorescence in the middle of the nucleus within the
presumed site of the DNA-free nucleolus. Thus, the short 10 min
TSA ampliﬁcation resulted in a highly sensitive, speciﬁc and
accurate localization of bound antibody probes.
Detection of cell surface bound KSHV comparing conventional FITC
and TSA enhancement
To determine whether TSA enhanced ﬂuorescence was capable
of detecting hapten-labeled KSHV bound to cell surfaces, HT1080
cells were ﬁxed with paraformaldehyde and incubated with
DNP-KSHV. Paraformaldehyde ﬁxation was used to preserve
cytoskeletal structures involved in the initial virus interaction
with the cell surface. Bound virus was detected using rat anti-
DNP IgG and a secondary antibody coupled to either HRP or FITC.
The FITC-labeled cells were visualized directly by confocal micro-
scopy, while the HRP-labeled cells were further reacted with
TSA488 to amplify the ﬂuorescent signal. The conventional FITC
antibody technique gave weak ﬂuorescence with a punctate
staining pattern for DNP-KSHV (Fig. 4A). In contrast, the TSA-
enhanced technique gave a strong staining pattern with DNP-
KSHV binding to distinct areas of the cells that were only weakly
ﬂuorescent with the FITC technique, including regions of cell
substratum contact and intercellular junctions (Fig. 4B). KSHV
binding was inhibited by heparin treatment (Fig. 4C), consistent
with previous KSHV binding studies (Akula et al., 2001b).
Hapten-labeled KSHV virions bind to speciﬁc cell surface domains
To further examine the cellular domains binding KSHV, con-
ﬂuent and sub-conﬂuent HT1080 cell cultures were ﬁxed and
incubated with puriﬁed DNP-labeled KSHV, and bound virus was
detected as above using the TSA method. The cell nuclei were
stained with TO-PRO 3. As a control, HT1080 cells were incubated
with a DNP-mock virus gradient fraction and stained using the
identical protocol. In conﬂuent cultures, DNP-KSHV strongly loca-
lized to distinct membrane regions, including intercellular junc-
tions (Fig. 5A, arrowhead) and a supranuclear region (Fig. 5A,
arrow), also shown in cross section (Fig. 5A, inset below). Large
areas of the cell surface adjacent to the junctional regions showed
little or no bound KSHV. In sub-conﬂuent cultures, KSHV bound to
supranuclear areas (Fig. 5B, chevron), intercellular junctions
(Fig. 5B, double arrows) and dorsal cell surface microdomains
(Fig. 5B and C, arrow) that were surrounded by adjacent virus-free
membrane regions (Fig. 5B, indicated with “n”). The dorsal micro-
domains were numerous with signiﬁcant size heterogeneity (Fig. 5B
and C). In addition, there was a high level of KSHV binding to
ﬁlopodia (Fig. 5B and C, arrowhead) and rufﬂed membranes (Fig. 5B
and D, open arrow) at the cell margins and points of cell substratum
contact. No cell-associated TSA488 signal was detected in HT1080
cells incubated with the DNP-labeled mock virus control (data not
shown). KSHV binding studies on live cells at 4 1C gave equivalent
results to the ﬁxed cells, validating our ﬁndings.
The morphology of the KSHV binding domains was analyzed
using Imaris 3D image analysis software. A region of interest (ROI)
Fig. 1. Puriﬁcation of hapten-labeled infectious KSHV. (A) KSHV virions were
concentrated by centrifugation onto an Opti-Prep cushion, labeled with NHS-
dinitrophenol (DNP) (50 mg/ml), and puriﬁed on a 10–40% Opti-Prep step gradient.
Aliquots of gradient fractions were analyzed by qPCR to quantitate KSHV DNA. The
infectivity of selected fractions (5, 7, 9, 11, 13, 15) was tested on Vero cells using an
anti-LANA antibody to detect latently infected cells, as described in Materials and
methods. (B) The effect of hapten incorporation on KSHV infectivity was assessed
after labeling puriﬁed virus from the peak gradient fractions with different
concentrations of DNP or biotin. The hapten-labeled virions were further puriﬁed
on an Opti-Prep step gradient and tested for infectivity on Vero cells.
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within Fig. 5B (boxed area) was selected for 3D surface rendering
(Fig. 6). The bound KSHV within the ROI is yellow while the nuclei
are red, and the intercellular junction is marked with a dashed
line. The dorsal surface KSHV-binding microdomains (open arrows),
and supranuclear KSHV (chevron, Fig. 6A) are indicated. To better
illustrate the restricted supranuclear KSHV domain, the rendering
was enlarged and rotated (Fig. 6B; see arrows for orientation). The
dorsal surface KSHV-binding microdomains outside of the ROI
Fig. 2. Fluorescent signal enhancement by tyramide signal ampliﬁcation (TSA) and use to detect labeled KSHV virions by confocal microscopy. (A) and (B) Fluorescent signal
enhancement by the TSA method was assessed using an indirect immunoassay to detect biotinylated IgG coupled to magnetic beads. The beads were incubated with mouse
anti-biotin IgG and dilutions of goat anti-mouse IgG conjugated with either (A) HRP (1:20,000) or (B) FITC (1:100). The HRP activity was detected using a 10 min
ampliﬁcation of TSA488. Fluorescence was visualized by confocal microscopy. (C)–(F) To determine if individual hapten-labeled KSHV virions could be detected by confocal
microscopy using TSA enhancement, gradient puriﬁed biotin-KSHV (10 mg/ml) was immobilized on poly-L-lysine coated dishes and incubated with (C) goat anti-biotin-HRP
antibody and TSA488 or (D) mouse anti-K8.1 antibody, which detects the K8.1 envelope glycoprotein of KSHV, and anti-mouse IgG-HRP, followed by TSA488 enhancement.
(E) and (F) gradient-puriﬁed DNP-KSHV virions (10 mg/ml) were double stained with the mouse anti-K8.1 and TSA488, as above, followed by rat anti-DNP and TSA647.
Individual virions (arrows) stained strongly for both K8.1 (green, 488 channel; (E)) and DNP (red, 647 channel; (F)) Bar¼5 mm.
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appeared ﬂat (Fig. 6B, star) while the rendering showed that the
KSHV-binding sites were “raised” structures (open arrow, Fig. 6B).
This is more clearly illustrated in Fig. 6C (XY view from above) and
Fig. 6D, (XZ view from the side) showing distinct supranuclear
KSHV-binding regions (chevron) and dorsal cell surface microdo-
mains with a raised morphology extending 4–5 mm in the Z axis
(Fig. 6D). The 3D rendering showed that the KSHV bound to the
supranuclear region was clearly distinct from adjacent KSHV
localized within dorsal surface microdomains (Fig. 6A–D).
We noted that the binding of KSHV was altered in a small
percentage of cells in the culture. Some cells showed clear binding
to the supranuclear region (chevron) and dorsal cell surface
microdomains (arrow) (Fig. 7A, upper panel cell 1). The DNA of
these cells reacted diffusely with TO-PRO 3 and was uniformly
distributed over the whole cell nucleus with a clear nuclear
margin (Fig. 7A, lower panel cell 1). 3D rendering showed that
cell 1 had a ﬂat and smooth nuclear membrane, characteristic of
an interphase cell (Fig. 7B, top view) and (Fig. 7C, side view). In
other cells, KSHV bound to extensive microvillar projections
extending over the entire cell surface (Fig. 7A; cells 2 and 3). The
TO-PRO 3 stained DNA in the nuclei of these cells showed obvious
concentration and aggregation contrasting sharply with the DNA
in interphase cell 1. Whereas the DNA in interphase cell 1
appeared diffuse and bordered by an intact nuclear membrane,
the DNA in cell 3 was aggregated on a central line, characteristic of
metaphase chromosomes in a mitotic cell lacking a deﬁned
nuclear membrane. 3D rendering of the TO-PRO 3 stain showed
that cells 2 and 3 had raised nuclei with individual condensed
chromosomes characteristic of mitotic cells (Fig. 7B and C; cells 2,
cell 3 not shown). 3D rendering of DNP-KSHV (yellow) showed a
high level of KSHV bound to surface projections on the mitotic
cells 2 and 3 compared to the amount of KSHV bound to the small
cell surface microdomains and supranuclear domain of interphase
cell 1 (Fig. 7D). The 3D rendering of cell 3 was “sliced” to reveal the
cell interior. This analysis demonstrated that the DNP-KSHV was
bound continuously across the membrane of the mitotic cell 3
extending from the cell margins over the nucleus, which had an
obvious raised morphology (Fig. 7D). The differences apparent in
the DNA structure of cells 2 and 3 suggest that they are indepen-
dently undergoing mitosis and are at different stages in the
process.
Up-regulation of KSHV binding sites on mitotic cells
The morphology of the cells stained in Fig. 7 suggested that the
DNP-KSHV was binding differentially to mitotic cells compared to
interphase cells. As with propidium iodide, the amount of TO-PRO
3 incorporated into DNA has been used to distinguish G0/G1 cells
(2n DNA content) from mitotic cells (4n) (Clevenger et al., 1985;
Ploeger et al., 2008). To further investigate the increased KSHV
binding on mitotic cells, Vero cells were treated with nocodazole
to synchronize them in mitosis (Zieve et al., 1980). Vero cells were
chosen because they are highly susceptible to KSHV infection and,
unlike HT1080 cells, remain adherent following low dose nocoda-
zole treatment allowing confocal analysis. The cells were ﬁxed and
incubated with DNP-KSHV and stained as in Fig. 7. The confocal
micrograph of KSHV cell binding (Fig. 8A) showed that 24 h of
nocodazole treatment (50 ng/ml) resulted in two cell populations
that differentially bound DNP-KSHV and TO-PRO 3. One cell
population stained strongly for both bound KSHV and nuclear
TO-PRO 3 (Fig. 8A, B, closed arrows), while the other cell popula-
tion stained weakly for both KSHV and TO-PRO 3 (Fig. 8A and B,
open arrows). Fig. 8B shows only the TO-PRO 3 ﬂuorescence
which was converted to greyscale. The ﬂuorescent pixels from
Fig. 3. Accuracy of TSA enhanced ﬂuorescence. The accuracy of deposition of TSA ﬂuorescence was determined by evaluating the localization of antibodies speciﬁc for cell
surface β3 integrin and two KSHV proteins, ORF 73 LANA and ORF 59 DNA polymerase processivity factor. Vero cells were infected with KSHV for 24 h. (A) and (B) Infected
cells were incubated with mouse anti-β3 integrin to label the cell surface. The cells were ﬁxed and the β3 integrin antibody was localized using anti-mouse IgG-HRP with
TSA488 enhancement (green). Subsequently, the cells were incubated with rat anti-LANA followed by anti-rat IgG-HRP with TSA594 enhancement (red). (B) High
magniﬁcation micrograph showing LANA nuclear localization detail. (C) and (D) Infected cells were ﬁxed and incubated with mouse anti-ORF59 followed by anti-mouse IgG-
HRP with TSA594 enhancement (red). The nuclei of all cells were stained with TO-PRO 3 (blue) and ﬂuorescence was examined by confocal microscopy. (D) A histogram of
the anti-ORF59 (red) and TO-PRO 3 (blue) ﬂuorescence along the white arrow in (C) across the two nuclei (x, y). The arrow crosses the apparent nucleolus of each cell, which
appears as a region of decreased TO-PRO 3 stained DNA. An arrowhead denotes the limit of the nuclear membrane in (C) and (D). Bar A¼20 mm, B¼5 mm, C¼10 mm.
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both DNP-KSHV and TO-PRO 3 were quantitated for intact cells
in the micrograph. The DNP-KSHV ﬂuorescence gave mean pixel
counts of 443728 and 20710 for the strongly and weakly staining
cells, respectively, which were signiﬁcantly different (Po0.0001).
The TO-PRO 3 ﬂuorescence gave mean pixel counts of 11979 and
38716 (threshold¼100) for the strongly and weakly staining cells
respectively, which were also signiﬁcantly different (P¼0.0005).
The DNP-KSHV and TO-PRO 3 ﬂuorescence levels for each cell
strongly correlated (R2¼0.6202; P¼0.0001) (Fig. 8C). Although we
could not identify metaphase chromosomes or condensed chroma-
tin in these cells due to the nocodazole treatment, the TO-PRO
3 ﬂuorescence data suggested that the weakly staining cells were
in G0/G1 interphase (2n) while the strongly staining cells were
mitotic as a result of the nocodazole block and had twice the DNA
content (4n).
To conﬁrm these ﬁndings, we incubated HT1080 cells with
DNP-KSHV and TO-PRO 3 and examined the cell culture by
confocal ﬂuorescence microscopy to identify mitotic cells having
characteristic metaphase chromosomes lined up in the cell center.
Cells displaying intact nuclear membranes and diffuse and uni-
form TO-PRO 3 staining were deﬁned as G0/G1 interphase (see cell
1, Fig. 7A, lower panel), while those cells displaying no nuclear
membrane and TO-PRO 3 stained chromosomes on the metaphase
plate were deﬁned as mitotic (see cell 3, Fig. 7A, lower panel).
A deﬁned area (46 mm2) of the nucleus was used to measure mean
ﬂuorescent intensity (MFI). As seen in Fig. 9A, the TO-PRO
3 ﬂuorescence intensity of the G0/G1 cells showed a tight cluster-
ing with an MFI of 12975. In contrast, the cells identiﬁed as
metaphase by microscopy showed approximately twice the DNA
content with an average TO-PRO 3 MFI of 23976 and the
difference was signiﬁcant (Po0.0001). The analysis of DNP-
KSHV bound to the G0/G1 and metaphase cells was determined
by counting anti-DNP/TSA488 pixels per cell with the minimal
intensity threshold set at 150. The levels of KSHV ﬂuorescence
bound to the G0/G1 cells closely clustered with an average count of
170723 pixel/cell (Fig. 9B). In contrast, the levels of KSHV
ﬂuorescence bound to the metaphase cells clustered with an
average count of 987783 pixel/cell, nearly six times the level of
the G0/G1 cells (Po0.0001). The DNP-KSHV and TO-PRO 3 ﬂuores-
cence levels for each cell strongly correlated (n¼26; R2¼0.7761;
Po0.0001) (Fig. 9C). These results demonstrate that the cell
surface binding sites for KSHV were strongly up-regulated in
mitotic cells in metaphase.
Discussion
In this study, we have characterized the cell surface structures
initiating KSHV attachment using gradient puriﬁed infectious
hapten-labeled virions visualized by confocal microscopy with a
highly sensitive ﬂuorescent signal enhancement procedure utiliz-
ing HRP-coupled antibodies and tyramides linked to different
Alexa ﬂuors. We determined that KSHV attachment sites were
not randomly distributed on the cell membrane, but instead, were
present in speciﬁc cellular domains, including actin-based ﬁlopo-
dia, lamellipodia, rufﬂed membranes, microvilli and intercellular
junctions. Similar binding speciﬁcities have been detected pre-
viously with individual viral envelope proteins (Birkmann et al.,
2001; Hahn et al., 2009). KSHV also bound to isolated microdo-
mains on the dorsal cell surface, which were heterogeneous in size
with a variable distribution that depended on the degree of cell
conﬂuence and the stage of the cell cycle. These KSHV binding
domains ranged from scarce on interphase cells to dense and
continuous on mitotic cells. KSHV also bound to a region over the
nucleus that was distinct from the microdomains in conﬂuent and
interphase cells. Due to the close proximity to the nuclear
envelope, virus entry from this site could have a direct route to
the nucleus for delivery of KSHV DNA during the infection process.
KSHV detection using labeled virus and TSA enhancement
provided a highly sensitive approach to identify cell surface
attachment domains. Speciﬁcity of virus binding was demon-
strated using multiple approaches. The DNP-mock virus controls
showed no cell binding, nor was there evidence of artifactual
ﬂuorescence derived from tyramide dispersion or sequential signal
ampliﬁcation steps using species speciﬁc HRP secondary antibo-
dies. In addition we detected different distributions of bound
KSHV on mitotic and interphase cells in the same experiment
showing speciﬁcity of binding. Finally, we showed that virus
binding is inhibited by heparin treatment, conﬁrming the results
of previous binding studies (Akula et al., 2001b; Birkmann et al.,
2001).
The microdomains binding KSHV are larger than nanoscale
lipid raft domains, and may represent larger “cross-linked” lipid
raft cluster domains whose size and distribution is mediated by
actin and myosin activity (Goswami et al., 2008; Mayor and Rao,
2004). Lipid rafts are known to contain some of the putative KSHV
binding receptors, including the HS proteoglycans, syndecan-1 and
syndecan-4 (Podyma-Inoue et al., 2012). However, the role of lipid
rafts in KSHV attachment and entry is unclear and may be
dependent on cell type, since KSHV infection of microvascular
endothelial cells was inhibited by drugs that disrupt lipid rafts
(Chakraborty et al., 2011; Raghu et al., 2007), while infection of
vascular endothelial cells (Greene and Gao, 2009) and human
foreskin ﬁbroblasts (Akula et al., 2003) was unaffected.
Previously, we identiﬁed the integrin αvβ3 as an entry receptor
for KSHV. We showed that puriﬁed αvβ3 integrin speciﬁcally
bound to KSHV virions, recognizing the RGD motif of KSHV virion
glycoprotein B, and anti-αvβ3 antibodies and RGD peptides
Fig. 4. Comparison of conventional FITC and TSA enhanced ﬂuorescence detection of cell surface-bound KSHV. HT1080 cells were incubated with DNP-KSHV followed by rat
anti-DNP IgG and a secondary anti-rat IgG antibody coupled to either (A) FITC or (B) HRP. The HRP-conjugates were detected with TSA488 enhancement. Arrowheads
identify intercellular junctions, while the arrow indicates regions of cell substratum contact. To examine the speciﬁcity of binding, HT1080 cells were incubated with
DNP-KSHV in the presence (C) or absence ((C), insert) of heparin, which is known to inhibit KSHV binding to cell surfaces, see text. Bar¼20 mm.
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blocked KSHV infection (Garrigues et al., 2008). Interestingly,
studies have shown that αvβ3 integrins are up-regulated on the
cell surface during mitosis (Anilkumar et al., 1996; Fender et al.,
2008). In this latter study using adenovirus, which contains a cell
attachment domain that interacts with both HS-proteoglycans
and αvβ3 integrin through multiple RGD motifs, they demon-
strated that HS-proteoglycans are mainly responsible for virus
attachment allowing interaction with αvβ3 integrin to induce
internalization. However, αvβ3 integrin mediated virus binding
and entry in HS-proteoglycan deﬁcient cells. They also detected
Fig. 5. Analysis of cell surface domains binding KSHV. Conﬂuent (A) or sub-conﬂuent ((B)–(D)) HT1080 cultures were ﬁxed and incubated with DNP-KSHV. KSHV was
detected with anti-DNP (TSA488, green) and nuclei were stained with TO-PRO 3 (blue). In conﬂuent cultures, KSHV bound preferentially to intercellular junctions ((A),
arrowhead) and to membrane areas directly over the nucleus ((A), arrow). Upper panel¼(x, y) top view. The dotted line indicates the position of the (x, z) side view in the
adjacent panel below, which shows supranuclear KSHV (arrow) and junctional KSHV (arrowhead). In sub-conﬂuent cultures, KSHV binding sites on the dorsal cell surface
were heterogeneous in size and number, forming distinct microdomains ((B) and (C), arrows) separated by membrane areas lacking KSHV ((B), indicated by “*”). KSHV also
localized to supranuclear domains ((B), chevron), intercellular junctions ((B), double arrow), ﬁlopodia ((B) and (C), arrowheads) and rufﬂed membranes at the cell margin
((B) and (D)), open arrows). Bar in (A) (C) and (D)¼10 mm; Bar in B¼20 mm.
Fig. 6. 3D surface rendering of KSHV supranuclear and cell surface microdomains. A region of interest (ROI) from Fig. 5B (box) was selected for 3D surface rendering with
surrounding ﬂuorescence (green) in 2D for comparison. KSHV and nuclear ﬂuorescence within the ROI were converted to yellow and red, respectively. The rendering in
(A) was rotated 1801, zoomed and tilted in (B). A vertical arrow is an orientation point. Distinct KSHV binding to intercellular junctions (dashed line), supranuclear domain
(chevron), and individual cell surface microdomains (open arrow) are visible (A) and (B). The ROI bisects the red nucleus to illustrate the distinct position of KSHV directly
over the nucleus. The original confocal projection appears ﬂat without structural detail (e.g. (B) indicated by “*”, green), while the rendered image of the microdomain edge
((B), open arrow, yellow) shows the complex raised morphology of the KSHV binding domain. (C)) (x, y) overhead view and (D)) (x, z) side views show that the KSHV binding
(chevron) was conﬁned to the supranuclear surface, while the cell surface microdomains have a raised morphology. The distance between the white spheres is 5.6 mm (D).
Bar in A¼10 mm; B¼5 mm; C, D¼2 mm.
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enhanced adenovirus binding to mitotic cells and determined that
the enhanced binding to mitotic cells was mediated by an up-
regulation of αvβ3 integrin on the cell surface. These studies
suggest that the increased binding of KSHV to mitotic cells that
we detected may be due to αvβ3 interactions. We have previously
seen that mitotic cells are more susceptible to KSHV infection, and
are currently exploring the role of αvβ3 in KSHV binding and entry
and its presence in the KSHV binding domains identiﬁed in
this study.
Materials and methods
Cell lines
The human HT1080 ﬁbrosarcoma cell line was a gift of
Dr. W. Carter. African green monkey Vero cells were from the
American Type Tissue Culture. HT 1080 and Vero cells were
maintained in DMEM containing 10% fetal bovine serum (FBS).
BCBL-1 cells latently infected with KSHV (Renne et al., 1996), were
cultured in RPMI complete medium with 10% FBS, 100 U/ml
penicillin, 100 mg/ml streptomycin, 1.0 mM HEPES, and 0.01%
2-mercaptoethanol at 37 1C.
Immunological reagents
The mouse monoclonal antibody against β3 integrin (clone B3A)
was purchased from Chemicon. Other antibody reagents included:
goat anti-mouse IgG-HRP, goat anti-mouse IgG-FITC, goat anti-rat
IgG-HRP, non-immune mouse IgG, and mouse anti-biotin IgG (Jack-
son Immunochemicals); mouse anti-K8.1A (clone 2A3), rat anti-LANA
(clone LN53), and mouse anti-ORF 59 (clone 11D1) (Advanced
Biotechnologies); goat anti-biotin-HRP, non-immune goat serum,
biotinylated goat IgG (Sigma); monoclonal rat anti-DNP (clone LO-
DNP-2; Invitrogen). Other reagents include: TSA-488, TSA-594, TSA-
647, TO-PRO 3, and SlowFade (Invitrogen).
KSHV labeling and puriﬁcation
KSHV virions from culture supernatants of TPA-treated BCBL
cells were concentrated 200-fold by centrifugation onto an Opti-
Prep cushion, as described previously (Garrigues et al., 2008). In
some experiments, aliquots of concentrated KSHV were labeled
with NHS-POE4-biotin (10–50 mg/ml) or NHS-dinitrophenol (DNP)
(10–50 mg/ml) and puriﬁed by centrifugation on a 20%, 25%, 30%,
and 40% Opti-Prep step gradient. Fractions were collected from the
top of the gradient using a BioComp gradient station (BioComp
Instruments, Inc., New Brunswick, Canada). KSHV DNA from each
fraction was quantiﬁed by real time PCR to detect v-cyclin
and infectivity of labeled virus was determined (see below). As a
labeling control, fractions from a mock virus gradient were
similarly labeled with DNP.
KSHV infection
Vero cells were infected with either unlabeled KSHV or various
fractions of labeled (DNP or biotin) KSHV for 3 h at 37 1C, washed,
and incubated for an additional 24 h. In some experiments, the
infected cells were then cooled to 4 1C and incubated with anti-β3
antibody for 1 h at 4 1C to detect cell surface αvβ3 integrin. The
cultures were then ﬁxed with 4% paraformaldehyde (PF) in PHEM/
sucrose (60 mM PIPES, 25 mM Hepes, 10 mM EGTA, 2 mM MgCl2,
4% sucrose) for 30 min at 37 1C. Free aldehydes were quenched
with 50 mM NH4Cl and the cells were permeabilized with 0.5%
NP-40/0.2% Tween 20. Endogenous peroxidase activity was inhib-
ited with 3% H2O2. The cells were incubated with 10% normal goat
Fig. 7. Enhanced KSHV binding to mitotic cells. HT1080 cells were incubated with DNP-KSHV and TO-PRO 3 (described in Fig. 5) to characterize the KSHV binding sites
(green) on three cells showing differential KSHV binding. (A) Distinct KSHV binding to supranuclear (chevron) and sparse dorsal cell surface microdomains (arrow) is shown
for cell 1 (Upper panel, outlined). KSHV bound to cell surface microvilli protruding from the entire dorsal surface on cells 2 and 3. TO-PRO 3 stained nuclei for cells 1, 2, and
3 are shown in the lower panel to demonstrate the diffuse DNA stain of cell 1 (interphase) compared to the condensed DNA in cells 2 and 3. Based on the chromosome
morphology, cell 3 appears to be in metaphase. (B) overhead and (C) side view surface renderings of nuclei in cells 1 and 2 are shown to illustrate the distinct condensed
chromatin and raised morphology of the nucleus of cell 2 compared to the ﬂat and smooth morphology of cell 1. Cell 1 has an intact nuclear membrane and therefore is
a G0/G1 interphase cell while cells 2 and 3 have condensed chromatin characteristic of mitotic cells. (D) A surface rendering of a ROI in panel A is shown with bound KSHV
(yellow). The mitotic cells 2 and 3 had high levels of KSHV bound extensively to microvilli across the entire cell surface, whereas the interphase cell 1 had KSHV bound to
sparse dorsal surface microdomains (arrow) and supranuclear region (chevron). Bars¼10 mm.
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serum (NGS) followed by 10% milk containing 1% NGS (blotto/NGS)
to block non-speciﬁc binding. For those cultures incubated with
anti-β3, the integrin was detected with anti-mouse IgG-HRP
followed by a 10 min TSA ampliﬁcation with TSA488. Residual
peroxidase activity was quenched with 1% H2O2 for 15 min. The
cells were then incubated with either rat anti-LANA monoclonal
antibody LN53 (1:500) or mouse anti-ORF 59 (1:500) to detect
KSHV infected cells. The cells were washed and bound antibody
was detected with a goat anti-rat or mouse IgG-HRP (1:100) and
TSA488 or TSA594 in αvβ3 integrin colocalization experiments.
The nuclei were stained with TO-PRO 3. The cells were analyzed by
confocal microscopy and the percent of cells expressing nuclear
LANA was determined manually (100–200 cells counted/group).
Sensitivity of tyramide signal ampliﬁcation (TSA)
NeutrAvidin (Pierce) was coupled to Dynabeads, as described
previously (Garrigues et al., 2008). Biotinylated goat IgG was
immobilized on NeutrAvidin beads (0.04 mg IgG/4.2 mg beads).
The beads were attached to poly L-lysine coated slides and
subsequently ﬁxed with 8% paraformaldehyde. The immobilized
beads were blocked with blotto/NGS. The biotinylated goat IgG
was detected with mouse anti-biotin (1:100) followed by anti-
mouse IgG-HRP (1:20,000) and TSA488 or, for comparison, the
same anti-mouse IgG conjugated to FITC (1:100) using the same
laser settings.
Accuracy of TSA localization
Vero cells were infected with unlabeled KSHV. In some experi-
ments, infected cells were ﬁxed, quenched, blocked, and incubated
with a mouse anti-ORF 59 and TSA594 as above. In other experi-
ments, live infected cells were double stained for KSHV LANA and
cell surface αvβ3 integrin, using the mouse anti-β3 antibody and
TSA488, followed by the rat anti-LANA antibody and TSA594 as
above. The accuracy of the TSA localization was assessed by
comparing the distribution of the LANA and ORF 59 TSA ﬂuores-
cence relative to the TO-PRO 3 stained nuclei using the proﬁle
function of the Zeiss LSM 4.2 software.
Detection of KSHV virion particles by TSA-enhanced
immunoﬂuorescence
Puriﬁed KSHV virions labeled with 10 mg/ml of either biotin or
DNP were immobilized on poly-L-lysine coated slides and stained
with either goat anti-biotin-HRP (1:100) or anti-K8.1 (1:100) and
TSA 488 as above. To assess virion integrity, individual virion
particles were double stained with mouse anti-K8.1 (1:100) and
TSA488, followed by rat anti-DNP and TSA647. The co-localization
of both TSA ﬂuorescent signals within individual KSHV particles
was determined by confocal microscopy to evaluate virus envelope
integrity.
Localization of cell-bound KSHV
HT1080 cells were seeded at 1104 cells per well (conﬂuent)
or 4103 cells per well (sub-conﬂuent) and cultured for 24–48 h.
Vero cells were treated with nocodazole (50 ng/ml) for 24 h to
block the cell cycle at mitosis. The cells were ﬁxed, quenched, and
blocked as above. The cells were washed with DMEM and
incubated for 3 h with gradient-puriﬁed DNP-KSHV (10 mg/ml
DNP) at a concentration of 1000 viral genomes/cell to be able to
saturate the virus binding sites. The cells were then washed, ﬁxed
and blocked. Bound DNP-KSHV was detected with monoclonal rat
anti-DNP diluted 1:100 in blotto/NGS followed by goat anti-rat
IgG-HRP (1:100) and TSA488. In some experiments, bound virus
was detected with the same secondary antibody conjugated to
FITC to compare the sensitivity of the TSA and FITC methods.
Inhibition of virus binding by heparin was done as above except
DNP-KSHV was pretreated with heparin (10 mg/ml) prior to and
during overnight virus incubation.
Confocal microscopy
Confocal images were generated on an LSM 5 Pascal system
(Zeiss) equipped with 401.3 NA and 631.4 NA objectives.
Image maximum projections were compiled from Z-stacks of
30–50 sections with intervals ranging from 0.3–0.4 mm and a Z-
distance of 10–14 mm. Confocal images were deconvolved using
AutoQuantAutoDeblur Gold CF (Media Cybernetics, Inc.). Three-
dimensional surface renderings of deconvolved images were done
with Imaris 7.3 (Bitplane AG). For the analysis of KSHV binding to
HT1080 mitotic cells, DNA content was estimated by comparing
TO-PRO 3 ﬂuorescent intensity of a 46 mm2 area over G0/G1 cells
with intact nuclear membranes compared to the same area over
metaphase chromosomes found at the cell center with no visible
nuclear membrane. For experiments using nocodazole, the TO-
PRO 3 intensity was determined for the whole cell since distinct
mitotic chromosomes in metaphase were not resolved. The LSM
software was used to measure ﬂuorescent intensity. To measure
Fig. 8. KSHV binding sites are up-regulated on mitotic Vero cells after nocodazole
treatment. Vero cells were treated with nocodazole (50 ng/ml) for 24 h to block the
cell cycle at mitosis. The cells were ﬁxed and incubated with DNP-KSHV and TO-
PRO 3 as in Fig. 5. (A) Micrograph of merged DNP-KSHV (green) and TO-PRO 3
(blue) ﬂuorescence. (B) TO-PRO 3 ﬂuorescence alone (greyscale). Solid and open
arrows indicate cells with high and low levels of DNP-KSHV and TO-PRO 3 staining,
respectively. (C) DNP-KSHV and TO-PRO 3 ﬂuorescent pixels were counted for each
cell and the correlationwas determined using Pearson0s correlation analysis. n¼24;
R2¼0.6202; P¼0.0001 (two-tailed, signiﬁcant at the 0.05 level). Bar¼20 mm.
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bound DNP-KSHV, cell boundaries were determined and marked
based on a combination of morphology and KSHV ﬂuorescence.
The number of ﬂuorescent pixels/cell for the anti-DNP antibody
was determined using the histogram function of the LSM software
with the threshold set at 150.
Data analysis
The GraphPad Prism software was used for statistical analysis.
The unpaired t test (two-tailed) was used to compare ﬂuorescent
pixel levels in the different cell populations. The Pearson0s correla-
tion analysis was employed to determine the correlation between
ﬂuorescent pixel levels.
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